Melanoma trials in France

In France 61 Also abroad 578

61 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Evaluation of Skin Tests in Biotherapy Allergies
Where
Angers
Age
18 years and over
People
70
Run by
University Hospital, Angers
See details and how to joinNCT06971848
No phaseTaking people
Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors
Where
Grenoble, Lyon
Age
18 years and over
People
80
Run by
Alpha Tau Medical LTD.
See details and how to joinNCT04068155
No phaseTaking people
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Where
Toulouse
Age
18 years and over
People
450
Run by
Institut Claudius Regaud
See details and how to joinNCT06967961
Phase 3Taking people
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Where
Nice, Paris
Age
18 years and over
People
520 worldwide
Run by
IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00
Phase 1/2Taking people
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Where
Lille, Paris, Toulouse, Villejuif
Age
18 years and over
People
240 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06413680 · EU 2025-523399-22-00
No phaseTaking people
Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1
Where
Angers, Besançon, Blois, Bordeaux, Brest, Dijon, Grenoble, La Rochelle, Le Mans, Lyon, Nantes, Paris, Rennes, Rouen, Saint-Herblain, Valence
Age
18 years and over
People
700
Run by
Nantes University Hospital
See details and how to joinNCT05856565
Phase 2/3Taking people
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Where
Lyon, Paris
Age
18 years and over
People
280 worldwide
Run by
Replimune, Inc.
See details and how to joinNCT06581406 · EU 2023-508784-68-00
Phase 4Taking people
ETCABio - Evaluation of Skin Tests in Biotherapy Allergies
Where
Angers
Age
18 years and over
People
140
Run by
Centre Hospitalier Universitaire D'Angers
See details and how to join2024-519812-15-00 · EU 2024-519812-15-00
No phaseTaking people
Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma
Where
Clermont-Ferrand
Age
18 years and over
People
50
Run by
Centre Jean Perrin
See details and how to joinNCT06550674
Phase 1Taking people
Study to evaluate the safety of MAQ-001 as monotherapy and combination therapy in patients with advanced cancers
Where
Lyon, Rennes Cedex, Toulouse Cedex 9, Villejuif Cedex
Age
18 years and over
People
30
Run by
MabQuest Therapeutics S.A.
See details and how to joinNCT06514651 · EU 2023-507774-41-00
Phase 3Taking people
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Where
Bordeaux, Lyon, Marseille, Paris, Toulouse Cedex 9, Villejuif
Age
18 years and over
People
540 worldwide
Run by
Immunocore Ltd
See details and how to joinNCT05549297 · EU 2022-502732-39-00
Phase 3Taking people
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Where
Bobigny, Boulogne-Billancourt, Caen, Dijon, Lille, Marseille, Nantes, Paris, Pierre-Bénite, Rouen, Toulouse, Valence, Villejuif
Age
18 years and over
People
680 worldwide
Run by
Immunocore Ltd
See details and how to joinNCT06112314
Phase 2Taking people
Neo-adjuvant Immunotherapy Master Trial for Localized Cancers
Where
Bordeaux, Lyon, Marseille, Paris, Pierre-Bénite, Villejuif
Age
12 years and over
People
200
Run by
UNICANCER
See details and how to joinNCT07262489 · EU 2025-522127-95-00
Phase 4Taking people
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Where
Lyon, Marseille, Villejuif
Age
18 years and over
People
50 worldwide
Run by
Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00
No phaseTaking people
Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma
Where
Nice
Age
18 years and over
People
20
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT05307289
No phaseTaking people
Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021
Where
Strasbourg
Age
18 years and over
People
221
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07302607
No phaseTaking people
Ovarian Reserve and Semen Parameters Evolution During Adjuvant Therapy in Melanoma
Where
Bordeaux, Marseille, Montpellier, Nantes, Nice, Nîmes, Paris, Toulouse, Villejuif
Age
18 years to 45 years
People
80
Run by
Assistance Publique Hopitaux De Marseille
See details and how to joinNCT05429138
No phaseTaking people
Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
Where
Paris
Age
18 years and over
People
700
Run by
Institut Curie
See details and how to joinNCT04424719
No phaseTaking people
French Clinical Datbase of Melanoma Patients (RIC-Mel)
Where
Nantes
Age
18 years and over
People
16,000
Run by
Nantes University Hospital
See details and how to joinNCT03315468
No phaseNot yet taking people in France
Efficay and Safety of DAROMUN on Patient Treated by Intralesionnal Injection: DAROMEL
Where
Nice
Age
18 years and over
People
70
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07046728
No phaseTaking people
APA (Adapted Physical Activity) for Patients With Advanced Melanoma
Where
Rouen
Age
18 years and over
People
50
Run by
University Hospital, Rouen
See details and how to joinNCT07031830
No phaseTaking people
Immune Profiles Evolution Under Immunotherapy for Melanoma
Where
Boulogne-Billancourt
Age
18 years and over
People
360
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT04576429
No phaseTaking people
Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy
Where
Nice
Age
18 years and over
People
20
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT03888950
No phaseTaking people
Real-life Pharmacological Monitoring of Encorafenib-Binimetinib in the Treatment of Metastatic Melanoma
Where
Boulogne-Billancourt
Age
18 years and over
People
66
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06774989
No phaseTaking people
Review of the Literature and Serie of Patients Who Underwent Reconstruction After Wide Local Excision of Nail Apparatus for Melanoma
Where
Nice
People
10
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT06861023